Helicos BioSciences Corporation (NASDAQ: HLCS) announced today that it will report its financial results for the third quarter of 2007 on Thursday, November 1, 2007, at 7:00 a.m. EDT, and hold a conference call at 9:00 a.m. EDT. Mr. Stanley Lapidus, Helicos' chairman and chief executive officer and Mr. Steve Lombardi, Helicos' president and chief operating officer, will lead the call.
Date: Thursday, November 1, 2007
Time: 9:00 a.m. EDT
Conference Call Numbers
Domestic: 888-213-3934
International: 913-312-0706
Webcast: www.helicosbio.com
About Helicos BioSciences
Helicos BioSciences Corporation is a life sciences company developing innovative genetic analysis technologies for the research, drug discovery and clinical diagnostics markets. The company has developed its proprietary True Single Molecule Sequencing technology to enable ultra-high-throughput genetic analysis based on the direct sequencing of single molecules of nucleic acids. The company's corporate headquarters are located at One Kendall Square, Building 700, Cambridge, MA 02139, and its telephone number is (617) 264-1800.
